Fetal Monitoring Market

Fetal Monitoring Market Size

Report	Details
Market Size Value	USD 3.7 Billion in 2023
Market Size Value	USD 12.2 Billion by 2030
CAGR	11.62%
Forecast Period	2024-2032
Base Year	2023
Historic Data	2020

Market Overview

Fetal Monitoring market is a part of healthcare industry that is devoted to creation, production and sale of cutting edge tools and technology intended to track the health of fetus during pregnancy and childbirth. The market gives medical practitioners the resources needed to evaluate and manage the health of both mother and fetus. It is an essential task for improving prenatal care. The increase in pregnancy-related problems such as gestational diabetes, preeclampsia placental abnormalities, etc. are fueling the demand for market. According to the World Health Organization (WHO), preeclampsia impacts 2% to 10% of pregnancies globally, 1.8% to 16.7% in developed countries compared to the lower rate of 0.4% in developed nations. The Fetal Monitoring Market is growing due to the increase in pregnancy related complications, technological advancements in monitoring devices, government initiatives for maternal and child health, and increase adoption of non-invasive and serve in preterm birth and infertility treatments. All the above factors are anticipated to accelerate the vital role of fetal monitoring in ensuring safe pregnancies and childbirth. Fetal Monitoring allows timely interventions and appropriate management of complicated pregnancies. New fetal monitoring solutions such as software-based and telemetry solutions are widely used in developing and underdeveloped countries. In future healthcare expenditure is expected to increase in India and China in line with economic growth in these nations which supports the Fetal Monitoring Market growth.

The key market players of fetal monitoring market such as: GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Koninklijke Philips N.V, Siemens Healthcare, Medtronic Plc, Arjohuntleigh(subsidiary of Getinge AB), Neoventa Medical AB, Natus Medical Incorporated, Spacelabs Healthcare, etc.

Technological advancements in fetal monitoring devices

Technological Advancements in fetal monitoring devices, such as ultrasound system, and portable fetal devices has improved the accuracy and efficiency of monitoring which contribute toward the market growth. Advance features such as real time data analysis, wireless connectivity, and portability have made monitoring more convenient for healthcare providers. Therefore, the technological advancements with cost effective devices in these nations offer lucrative fetal monitoring market opportunity. Electronic fetal monitoring (EFM) is becoming increasingly mainstream in the healthcare sector. This trend of EFM has given rise to non-invasive assessment via Doppler ultrasound sensor or by means of fetal ECG (Electrocardiogram) sensor on the fetal scalp.

Market Dynamics

Drivers:

• Increasing pregnancy-related complications
• Rising fetal abnormalities and defects
• Increasing adoption of infertility treatment
• Technological advancement in fetal monitoring devices

Opportunities:

• Development of portable and advance fetal monitors
• Non-invasive prenatal testing and monitoring technologies
• Government initiatives to reduce infant mortality rate

Development of portable and advance fetal monitors

The leading producers in the industry are diversifying their product offerings to include accurate, secure, and reasonably priced wireless and portable monitoring systems. For instance, in November 2021, Apogee 6 series of color Doppler ultrasound imaging solutions was introduced by Shantou Institute of Ultrasonic Instruments Co., Ltd. (China). This series includes the Apogee 6200, apogee 6300, and Apogee 6500 color Doppler ultrasound system which provides a solution for cardiac, abdominal, vascular, urology, and OB/GYN clinical applications. Technologies like NIPT, which involves analyzing cell-free fetal DNA in the mother's blood, offers a safer and more accurate alternative to traditional invasive procedures such as amniocentesis and chorionic villus sampling for detecting chromosomal abnormalities such as Down syndrome. These technologies have changed prenatal care by offering early and dependable information about the fetus, reducing the risk of complications with invasive procedures. As NIPT becomes more widely available and affordable, there is a growing opportunity to expand its use in routine prenatal care, leading to improved outcomes for mothers and babies and driving growth in the market

The Fetal Monitoring Market is dominated by North America.

North America is expected to dominate the market due to various factors such as technological advancements, increased patient awareness, and improved reimbursement policies. This trend is expected to continue over the forecast period. North America accounted for a major share of the fetal monitoring market in 2022, and is expected to maintain its dominance during the forecast period. The presence of several major players, such as Koninklijke Philips N.V., General Electric Company, Cardinal Health, Siemens AG and advancement in manufacturing technology of fetal monitoring devices drive the growth of the market in the region.

Asia-Pacific is expected to grow at the highest rate during the fetal monitoring market forecast period market growth in this region is attributable to presence of medical devices companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Growing cases of complications in pregnancy and advancements in the field of healthcare also contribute to the market growth. Asia-Pacific is densely populated in which India and China being most populated countries which offers profitable opportunities for key players operating in the fetal monitoring market which registers the faster growth rate during the forecast period.

Non-Invasive Segment anticipated to hold largest market share during forecast period

The non-invasive segment dominated the market and accounted for largest market share in the year 2023 and is expected to witness the highest growth during the forecast period. Non-invasive methods such as external electronic fetal monitoring (EFM) offer a safe and comfortable monitoring experience for expectant mothers, eliminating the need for invasive procedures and the associated discomfort and risks. Non-invasive methods stand out for their ability to minimize the risk of infection, a critical consideration during pregnancy. These methods are widely adopted as the standard for routine prenatal care, facilitating their widespread use in healthcare user-friendly technology and cost-effectiveness make them an economically viable choice for healthcare facilities. Therefore, these combined attributes have solidified the non-invasive segment's dominance in the market, positioning it as the preferred method for monitoring fetal well being during pregnancy.

Major segmentations are distributed as follows:

• By Products

• Electronic Fetal Monitoring,
• Accessories & Consumables Ultrasound Devices
•  Fetal Electrodes

• By Methods

• Invasive
• Non-Invasive

• By Applications

• Intrapartum Fetal Monitoring
•  Antepartum Fetal Monitoring

• By Portability

• Portable
• Non-Portable

• By End User

• Hospitals
• Gynaecological Clinics
• Homecare

• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • BENELUX
    • CIS & Russia
    • Nordics
    • Austria
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Nigeria
    • Egypt
    • Israel
    • Turkey
    • Rest of MEA

Recent Developments

• In May 2021, Medtronic plc introduced the Sonar Med airway monitoring system. This system utilizes acoustic technology to continuously assess endotracheal tube obstruction and verify its position in real-time. This provides clinicians with critical information needed to make more informed decisions, particularly for neonates and infants, potentially saving lives
• In May 2022, Healthcare (US) and Pulsenmore (Israel) signed an agreement to accelerate the adoption of Pulsenmore’s home care ultrasound solutions and support their goal to pursue US FDA clearance and commercial expansion.
• In April 2022, ArchiMed group (France) acquired Natus Medical Incorporated (US0 to expand the reach and breadth of Natus market-leading products, reinforcing the focus on research and development and pursuing acquisitions of complementary businesses.

Answers to Following Key Questions

• What will be the fetal monitoring market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers in the Fetal Monitoring Market?
• What are the main forces behind worldwide fetal monitoring market? Which companies dominate fetal monitoring market?
• Which companies dominate fetal monitoring market? Which business possibilities, dangers, and tactics did they embrace in the market?
• What are the main geographic areas for various trades that are anticipated to have astounding expansion over the fetal monitoring market?
• What are the main geographical areas for various industries that are anticipated to observe astounding expansion for fetal monitoring market?
• What are the dominant revenue-generating regions for fetal monitoring market, as well as regional growth trends?
• By the end of the forecast period, what will the market size and growth rate be?
• What are the main fetal monitoring market trends that are influencing the market's expansion?
• Which key product categories dominate fetal monitoring market? What is Fetal Monitoring Market’s main applications?
• In the coming years, which fetal monitoring market technology will dominate the market?